277 related articles for article (PubMed ID: 27189273)
1. Re-Irradiation for Recurrent Gliomas: Treatment Outcomes and Prognostic Factors.
Lee J; Cho J; Chang JH; Suh CO
Yonsei Med J; 2016 Jul; 57(4):824-30. PubMed ID: 27189273
[TBL] [Abstract][Full Text] [Related]
2. High-dose salvage re-irradiation for recurrent/progressive adult diffuse glioma: healing or hurting?
Gupta T; Maitre M; Maitre P; Goda JS; Krishnatry R; Chatterjee A; Moiyadi A; Shetty P; Epari S; Sahay A; Patil V; Jalali R
Clin Transl Oncol; 2021 Jul; 23(7):1358-1367. PubMed ID: 33528810
[TBL] [Abstract][Full Text] [Related]
3. Moving Second Courses of Radiotherapy Forward: Early Re-Irradiation After Surgical Resection for Recurrent Gliomas Improves Efficacy With Excellent Tolerability.
Combs SE; Kessel KA; Hesse J; Straube C; Zimmer C; Schmidt-Graf F; Schlegel J; Gempt J; Meyer B
Neurosurgery; 2018 Dec; 83(6):1241-1248. PubMed ID: 29462372
[TBL] [Abstract][Full Text] [Related]
4. Timing of re-irradiation in recurrent high-grade gliomas: a single institution study.
Zemlin A; Märtens B; Wiese B; Merten R; Steinmann D
J Neurooncol; 2018 Jul; 138(3):571-579. PubMed ID: 29520609
[TBL] [Abstract][Full Text] [Related]
5. Validation of an established prognostic score after re-irradiation of recurrent glioma.
Kessel KA; Hesse J; Straube C; Zimmer C; Schmidt-Graf F; Schlegel J; Meyer B; Combs SE
Acta Oncol; 2017 Mar; 56(3):422-426. PubMed ID: 28075197
[TBL] [Abstract][Full Text] [Related]
6. Re-irradiation for recurrent glioma: outcome evaluation, toxicity and prognostic factors assessment. A multicenter study of the Radiation Oncology Italian Association (AIRO).
Navarria P; Minniti G; Clerici E; Tomatis S; Pinzi V; Ciammella P; Galaverni M; Amelio D; Scartoni D; Scoccianti S; Krengli M; Masini L; Draghini L; Maranzano E; Borzillo V; Muto P; Ferrarese F; Fariselli L; Livi L; Pasqualetti F; Fiorentino A; Alongi F; di Monale MB; Magrini S; Scorsetti M
J Neurooncol; 2019 Mar; 142(1):59-67. PubMed ID: 30515706
[TBL] [Abstract][Full Text] [Related]
7. Extent of re-excision, sequence/timing of salvage re-irradiation, and disease-free interval impact upon clinical outcomes in recurrent/progressive ependymoma.
Gupta T; Maitre M; Gupta P; Krishnatry R; Chatterjee A; Moiyadi A; Shetty P; Singh V; Chinnaswamy G; Epari S; Sahay A; Patil V; GodaSastri J
J Neurooncol; 2020 Apr; 147(2):405-415. PubMed ID: 32072441
[TBL] [Abstract][Full Text] [Related]
8. Generation and validation of a prognostic score to predict outcome after re-irradiation of recurrent glioma.
Combs SE; Edler L; Rausch R; Welzel T; Wick W; Debus J
Acta Oncol; 2013 Jan; 52(1):147-52. PubMed ID: 22686472
[TBL] [Abstract][Full Text] [Related]
9. A Retrospective Review of Re-irradiating Patients' Recurrent High-grade Gliomas.
Klobukowski L; Falkov A; Chelimo C; Fogh SE
Clin Oncol (R Coll Radiol); 2018 Sep; 30(9):563-570. PubMed ID: 29891395
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of salvage fractionated re-irradiation combined with bevacizumab for recurrent high-grade gliomas that progressed after bevacizumab treatment*.
Yonezawa H; Ohno M; Igaki H; Miyakita Y; Takahashi M; Tamura Y; Shima S; Matsushita Y; Ichimura K; Narita Y
Jpn J Clin Oncol; 2021 Jul; 51(7):1028-1035. PubMed ID: 33959771
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of Salvage Re-irradiation With Stereotactic Radiotherapy for Recurrent Glioma Using CyberKnife.
Adachi K; Hayashi K; Kagawa N; Kinoshita M; Sumida I; Akino Y; Shiomi H; Tamari K; Suzuki O; Hirayama R; Kijima N; Isohashi F; Seo Y; Otani K; Kishima H; Ogawa K
Anticancer Res; 2019 Jun; 39(6):2935-2940. PubMed ID: 31177132
[TBL] [Abstract][Full Text] [Related]
12. Patterns of re-irradiation for recurrent gliomas and validation of a prognostic score.
Post CCB; Kramer MCA; Smid EJ; van der Weide HL; Kleynen CE; Heesters MAAM; Verhoeff JJC
Radiother Oncol; 2019 Jan; 130():156-163. PubMed ID: 30446315
[TBL] [Abstract][Full Text] [Related]
13. Re-irradiation of recurrent gliomas: pooled analysis and validation of an established prognostic score-report of the Radiation Oncology Group (ROG) of the German Cancer Consortium (DKTK).
Combs SE; Niyazi M; Adeberg S; Bougatf N; Kaul D; Fleischmann DF; Gruen A; Fokas E; Rödel CM; Eckert F; Paulsen F; Oehlke O; Grosu AL; Seidlitz A; Lattermann A; Krause M; Baumann M; Guberina M; Stuschke M; Budach V; Belka C; Debus J; Kessel KA
Cancer Med; 2018 May; 7(5):1742-1749. PubMed ID: 29573214
[TBL] [Abstract][Full Text] [Related]
14. Re-irradiation for recurrent glioma- the NCI experience in tumor control, OAR toxicity and proposal of a novel prognostic scoring system.
Krauze AV; Peters C; Cheng J; Ning H; Mackey M; Rowe L; Cooley-Zgela T; Smart DD; Camphausen K
Radiat Oncol; 2017 Nov; 12(1):191. PubMed ID: 29187219
[TBL] [Abstract][Full Text] [Related]
15.
Fleischmann DF; Unterrainer M; Bartenstein P; Belka C; Albert NL; Niyazi M
J Neurooncol; 2017 Apr; 132(2):277-286. PubMed ID: 28102485
[TBL] [Abstract][Full Text] [Related]
16. Recurrent low-grade gliomas: the role of fractionated stereotactic re-irradiation.
Combs SE; Ahmadi R; Schulz-Ertner D; Thilmann C; Debus J
J Neurooncol; 2005 Feb; 71(3):319-23. PubMed ID: 15735924
[TBL] [Abstract][Full Text] [Related]
17. Re-irradiation with and without bevacizumab as salvage therapy for recurrent or progressive high-grade gliomas.
Hundsberger T; Brügge D; Putora PM; Weder P; Weber J; Plasswilm L
J Neurooncol; 2013 Mar; 112(1):133-9. PubMed ID: 23314822
[TBL] [Abstract][Full Text] [Related]
18. Hypofractionated Re-irradiation after Maximal Surgical Resection for Recurrent Glioblastoma: Therapeutic Adequacy and Its Prognosticators of Survival.
Lee J; Ahn SS; Chang JH; Suh CO
Yonsei Med J; 2018 Mar; 59(2):194-201. PubMed ID: 29436186
[TBL] [Abstract][Full Text] [Related]
19. [Role of radiotherapy in recurrent gliomas].
Dhermain F; de Crevoisier R; Parker F; Cioloca C; Kaliski A; Beaudre A; Lefkopoulos D; Armand JP; Haie-Meder C
Bull Cancer; 2004 Nov; 91(11):883-9. PubMed ID: 15582893
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the optimal re-irradiation dose for locally recurrent esophageal squamous cell carcinoma after definitive radiotherapy.
Xu X; Wang Z; Jiang S; Shang Y; Wu Y
Radiat Oncol; 2019 Nov; 14(1):191. PubMed ID: 31684983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
